{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:33Z","timestamp":1740107733358,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["0045143600000"],"award-info":[{"award-number":["0045143600000"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10067-024-07091-3","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T21:02:03Z","timestamp":1724706123000},"page":"3157-3166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Internet-based enrollment of a myositis patient cohort\u2014a national experience"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2830-7675","authenticated-orcid":false,"given":"Raisa Lomanto","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiri","family":"Keret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nantakarn","family":"Pongtarakulpanit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siamak","family":"Moghadam-Kia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester V.","family":"Oddis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"issue":"5","key":"7091_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4155\/cli.14.139","volume":"5","author":"O Johnson","year":"2015","unstructured":"Johnson O (2015) An evidence-based approach to conducting clinical trial feasibility assessments. Clin Investig 5(5):491\u2013499. https:\/\/doi.org\/10.4155\/cli.14.139","journal-title":"Clin Investig"},{"issue":"3","key":"7091_CR2","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/rheumatology\/kead281","volume":"63","author":"G Marder","year":"2024","unstructured":"Marder G, Quach T, Chadha P, Nandkumar P, Tsang J, Levine T, Schiopu E, Furie R, Davidson A, Narain S (2024) Belimumab treatment of adult idiopathic inflammatory myopathy. Rheumatology (Oxford) 63(3):742\u2013750. https:\/\/doi.org\/10.1093\/rheumatology\/kead281","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7091_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2478\/rir-2022-0031","volume":"3","author":"A Coler-Reilly","year":"2022","unstructured":"Coler-Reilly A, Graef ER, Kim AHJ, Liew JW, Putman MS, Sattui SE, Young KJ, Sparks JA (2022) Social media for research discourse, dissemination, and collaboration in rheumatology. Rheumatol Immunol Res 3(4):169\u2013179. https:\/\/doi.org\/10.2478\/rir-2022-0031","journal-title":"Rheumatol Immunol Res"},{"issue":"6","key":"7091_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/rheumatology\/keaa191","volume":"59","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R (2020) The rheumatology community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology (Oxford) 59(6):1204\u20131206. https:\/\/doi.org\/10.1093\/rheumatology\/keaa191","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"7091_CR5","doi-asserted-by":"publisher","first-page":"e38015","DOI":"10.2196\/38015","volume":"24","author":"EM Darko","year":"2022","unstructured":"Darko EM, Kleib M, Olson J (2022) Social media use for research participant recruitment: integrative literature review. J Med Internet Res 24(8):e38015. https:\/\/doi.org\/10.2196\/38015","journal-title":"J Med Internet Res"},{"issue":"9","key":"7091_CR6","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1016\/S2665-9913(21)00221-6","volume":"3","author":"R Felten","year":"2021","unstructured":"Felten R, Kawka L, Dubois M, Ugarte-Gil MF, Fuentes-Silva Y, Piga M, Arnaud L (2021) Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study. Lancet Rheumatol 3(9):e613\u2013e615. https:\/\/doi.org\/10.1016\/S2665-9913(21)00221-6","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"7091_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/rheumatology\/keac305","volume":"62","author":"P Sen","year":"2022","unstructured":"Sen P, Ravichandran N, Nune A, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Parodis I, Selva O\u2019Callaghan A, Nikiphorou E, Chatterjee T, Tan AL, Cavagna L, COVAD Study Group (2022) COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study. Rheumatology (Oxford) 62(1):65\u201376. https:\/\/doi.org\/10.1093\/rheumatology\/keac305","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"7091_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/acr2.11448","volume":"4","author":"V Tsaltskan","year":"2022","unstructured":"Tsaltskan V, Nguyen K, Eaglin C, Holers VM, Deane KD, Firestein GS (2022) Comparison of web-based advertising and a social media platform as recruitment tools for underserved and hard-to-reach populations in rheumatology clinical research. ACR Open Rheumatol 4(7):623\u2013630. https:\/\/doi.org\/10.1002\/acr2.11448","journal-title":"ACR Open Rheumatol"},{"issue":"12","key":"7091_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10916-022-01881-5","volume":"46","author":"SR MacEwan","year":"2022","unstructured":"MacEwan SR, Sieck CJ, McAlearney AS (2022) Geographic location impacts patient portal use via desktop and mobile devices. J Med Syst 46(12):97. https:\/\/doi.org\/10.1007\/s10916-022-01881-5","journal-title":"J Med Syst"},{"key":"7091_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.invent.2018.03.006","volume":"12","author":"LG Morrison","year":"2018","unstructured":"Morrison LG, Geraghty AWA, Lloyd S, Goodman N, Michaelides DT, Hargood C, Weal M, Yardley L (2018) Comparing usage of a web and app stress management intervention: an observational study. Internet Interv 12:74\u201382. https:\/\/doi.org\/10.1016\/j.invent.2018.03.006","journal-title":"Internet Interv"},{"issue":"1","key":"7091_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Prim 7(1):1\u201322. https:\/\/doi.org\/10.1038\/s41572-021-00321-x","journal-title":"Nat Rev Dis Prim"},{"key":"7091_CR12","unstructured":"Budget (2014) National Institutes of Health (NIH). https:\/\/www.nih.gov\/about-nih\/what-we-do\/budget.\u00a0Accessed\u00a014 Mar 2014"},{"issue":"7","key":"7091_CR13","doi-asserted-by":"publisher","first-page":"e231921","DOI":"10.1001\/jamahealthforum.2023.1921","volume":"4","author":"EW Zhou","year":"2023","unstructured":"Zhou EW, Jackson MJ, Ledley FD (2023) Spending on phased clinical development of approved drugs by the US National Institutes of Health compared with industry. JAMA Health Forum 4(7):e231921. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.1921","journal-title":"JAMA Health Forum"},{"issue":"2","key":"7091_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/picr.PICR_206_19","volume":"11","author":"N Chaudhari","year":"2020","unstructured":"Chaudhari N, Ravi R, Gogtay NJ, Thatte UM (2020) Recruitment and retention of the participants in clinical trials: challenges and solutions. Perspect Clin Res 11(2):64\u201369. https:\/\/doi.org\/10.4103\/picr.PICR_206_19","journal-title":"Perspect Clin Res"},{"key":"7091_CR15","unstructured":"Ray K, Tosti B (2017) Transforming patient recruitment through patient and site engagement. IQVIA"},{"issue":"1","key":"7091_CR16","doi-asserted-by":"publisher","first-page":"e2250996","DOI":"10.1001\/jamanetworkopen.2022.50996","volume":"6","author":"C Shadbolt","year":"2023","unstructured":"Shadbolt C, Naufal E, Bunzli S, Price V, Rele S, Schilling C, Thuraisingam S, Lohmander LS, Balogh ZJ, Clarke P, Choong P, Dowsey M (2023) Analysis of rates of completion, delays, and participant recruitment in randomized clinical trials in surgery. JAMA Netw Open 6(1):e2250996. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.50996","journal-title":"JAMA Netw Open"},{"issue":"1","key":"7091_CR17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1186\/s13063-021-05818-0","volume":"22","author":"M Briel","year":"2021","unstructured":"Briel M, Elger BS, McLennan S, Schandelmaier S, von Elm E, Satalkar P (2021) Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada. Trials 22(1):844. https:\/\/doi.org\/10.1186\/s13063-021-05818-0","journal-title":"Trials"},{"issue":"5","key":"7091_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1177\/17407745211015924","volume":"18","author":"C Zahren","year":"2021","unstructured":"Zahren C, Harvey S, Weekes L, Bradshaw C, Butala R, Andrews J, O\u2019Callaghan S (2021) Clinical trials site recruitment optimisation: guidance from clinical trials: impact and quality. Clin Trials (London) 18(5):594\u2013605. https:\/\/doi.org\/10.1177\/17407745211015924","journal-title":"Clin Trials (London)"},{"key":"7091_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cct.2018.01.003","volume":"66","author":"GD Huang","year":"2018","unstructured":"Huang GD, Bull J, Johnston McKee K, Mahon E, Harper B, Roberts JN, CTTI Recruitment Project Team (2018) Clinical trials recruitment planning: a proposed framework from the Clinical Trials Transformation Initiative. Contemp Clin Trials 66:74\u201379. https:\/\/doi.org\/10.1016\/j.cct.2018.01.003","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"7091_CR20","doi-asserted-by":"publisher","first-page":"e22179","DOI":"10.2196\/22179","volume":"22","author":"M Br\u00f8gger-Mikkelsen","year":"2020","unstructured":"Br\u00f8gger-Mikkelsen M, Ali Z, Zibert JR, Andersen AD, Thomsen SF (2020) Online patient recruitment in clinical trials: systematic review and meta-analysis. J Med Internet Res 22(11):e22179. https:\/\/doi.org\/10.2196\/22179","journal-title":"J Med Internet Res"},{"issue":"6","key":"7091_CR21","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.2196\/jmir.5502","volume":"18","author":"L Carter-Harris","year":"2016","unstructured":"Carter-Harris L, Bartlett Ellis R, Warrick A, Rawl S (2016) Beyond traditional newspaper advertisement: leveraging Facebook-targeted advertisement to recruit long-term smokers for research. J Med Internet Res 18(6):e117. https:\/\/doi.org\/10.2196\/jmir.5502","journal-title":"J Med Internet Res"},{"issue":"7","key":"7091_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jsxm.2020.04.005","volume":"17","author":"J Benoit-Piau","year":"2020","unstructured":"Benoit-Piau J, Dumoulin C, Carroll MS, Mayrand MH, Bergeron S, Khalif\u00e9 S, Waddell G, Morin M, Provoked Vestibulodynia (PVD) Study Group (2020) Efficiency and cost: e-recruitment is a promising method in gynecological trials. J Sex Med 17(7):1304\u20131311. https:\/\/doi.org\/10.1016\/j.jsxm.2020.04.005","journal-title":"J Sex Med"},{"issue":"2","key":"7091_CR23","doi-asserted-by":"publisher","first-page":"zsz254","DOI":"10.1093\/sleep\/zsz254","volume":"43","author":"CM Depner","year":"2019","unstructured":"Depner CM, Cheng PC, Devine JK, Khosla S, de Zambotti M, Robillard R, Vakulin A, Drummond SPA (2019) Wearable technologies for developing sleep and circadian biomarkers: a summary of workshop discussions. Sleep 43(2):zsz254. https:\/\/doi.org\/10.1093\/sleep\/zsz254","journal-title":"Sleep"},{"issue":"19","key":"7091_CR24","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1001\/jama.2021.4609","volume":"325","author":"MM McDermott","year":"2021","unstructured":"McDermott MM, Newman AB (2021) Remote research and clinical trial integrity during and after the coronavirus pandemic. JAMA 325(19):1935\u20131936. https:\/\/doi.org\/10.1001\/jama.2021.4609","journal-title":"JAMA"},{"issue":"10","key":"7091_CR25","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1093\/rheumatology\/kead057","volume":"62","author":"PRN Sen","year":"2023","unstructured":"Sen PRN, Houshmand N, Moghadam Kia S, Joshi M, Saha S, Jagtap K, Agarwal V, Nune A, Nikiphorou E, Tan AL, Shinjo SK, Ziade N, Velikova T, Milchert M, Parodis I, Gracia-Ramos AE, Cavagna L, Kuwana M, Gupta L (2023) Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys. Rheumatology (Oxford) 62(10):3291\u20133301. https:\/\/doi.org\/10.1093\/rheumatology\/kead057","journal-title":"Rheumatology (Oxford)"},{"key":"7091_CR26","doi-asserted-by":"publisher","first-page":"100318","DOI":"10.1016\/j.conctc.2019.100318","volume":"14","author":"K Baca-Motes","year":"2019","unstructured":"Baca-Motes K, Edwards AM, Waalen J, Edmonds S, Mehta RR, Ariniello L, Ebner GS, Talantov D, Fastenau JM, Carter CT, Sarich TC, Felicione E, Topol EJ, Steinhubl SR (2019) Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: lessons from the randomized, controlled mSToPS trial. Contemp Clin Trials Commun 14:100318. https:\/\/doi.org\/10.1016\/j.conctc.2019.100318","journal-title":"Contemp Clin Trials Commun"},{"issue":"2","key":"7091_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ajcn\/nqab352","volume":"115","author":"M Ellington","year":"2021","unstructured":"Ellington M, Connelly J, Clayton P, Lorenzo CY, Collazo-Velazquez C, Trak-Fellermeier MA, Palacios C (2021) Use of Facebook, Instagram, and Twitter for recruiting healthy participants in nutrition-, physical activity\u2013, or obesity-related studies: a systematic review. Am J Clin Nutr 115(2):514\u2013533. https:\/\/doi.org\/10.1093\/ajcn\/nqab352","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"7091_CR28","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.2196\/jmir.7071","volume":"19","author":"C Whitaker","year":"2017","unstructured":"Whitaker C, Stevelink S, Fear N (2017) The use of Facebook in recruiting participants for health research purposes: a systematic review. J Med Internet Res 19(8):e290. https:\/\/doi.org\/10.2196\/jmir.7071","journal-title":"J Med Internet Res"},{"issue":"2","key":"7091_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/ntr\/ntt157","volume":"16","author":"M Frandsen","year":"2014","unstructured":"Frandsen M, Walters J, Ferguson SG (2014) Exploring the viability of using online social media advertising as a recruitment method for smoking cessation clinical trials. Nicotine Tob Res: Off J Soc Res Nicotine Tob 16(2):247\u2013251. https:\/\/doi.org\/10.1093\/ntr\/ntt157","journal-title":"Nicotine Tob Res: Off J Soc Res Nicotine Tob"},{"issue":"6","key":"7091_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1037\/a0039210","volume":"70","author":"M Kosinski","year":"2015","unstructured":"Kosinski M, Matz SC, Gosling SD, Popov V, Stillwell D (2015) Facebook as a research tool for the social sciences: opportunities, challenges, ethical considerations, and practical guidelines. Am Psychol 70(6):543\u2013556. https:\/\/doi.org\/10.1037\/a0039210","journal-title":"Am Psychol"},{"key":"7091_CR31","doi-asserted-by":"publisher","first-page":"e39262","DOI":"10.2196\/39262","volume":"25","author":"J Applequist","year":"2023","unstructured":"Applequist J, Burroughs C, Merkel PA, Rothenberg M, Trapnell B, Desnick R, Sahin M, Krischer J (2023) Direct-to-consumer recruitment methods via traditional and social media to aid in research accrual for clinical trials for rare diseases: comparative analysis study. J Med Internet Res 25:e39262. https:\/\/doi.org\/10.2196\/39262","journal-title":"J Med Internet Res"},{"issue":"2","key":"7091_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/gim.0b013e3182310ba0","volume":"14","author":"DC Landy","year":"2012","unstructured":"Landy DC, Brinich MA, Colten ME, Horn EJ, Terry SF, Sharp RR (2012) How disease advocacy organizations participate in clinical research: a survey of genetic organizations. Genet Med: Off J Am Coll Med Genet 14(2):223\u2013228. https:\/\/doi.org\/10.1038\/gim.0b013e3182310ba0","journal-title":"Genet Med: Off J Am Coll Med Genet"},{"key":"7091_CR33","doi-asserted-by":"publisher","unstructured":"Nipp RD, Hong K, Paskett ED (2019). Overcoming barriers to clinical trial enrollment. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 39:105\u2013114.https:\/\/doi.org\/10.1200\/EDBK_243729","DOI":"10.1200\/EDBK_243729"},{"issue":"6","key":"7091_CR34","doi-asserted-by":"publisher","first-page":"e4065","DOI":"10.1111\/hsc.13799","volume":"30","author":"H Garrido-Hernansaiz","year":"2022","unstructured":"Garrido-Hernansaiz H (2022) The use of online social media for the recruitment of people living with HIV in Spain and Latin America: lessons from two studies. Health Soc Care Community 30(6):e4065\u2013e4073. https:\/\/doi.org\/10.1111\/hsc.13799","journal-title":"Health Soc Care Community"},{"issue":"4","key":"7091_CR35","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3233\/JPD-202163","volume":"10","author":"CG Tarolli","year":"2020","unstructured":"Tarolli CG, Andrzejewski K, Zimmerman GA, Bull M, Goldenthal S, Auinger P, O\u2019Brien M, Dorsey ER, Biglan K, Simuni T (2020) Feasibility, reliability, and value of remote video-based trial visits in Parkinson\u2019s disease. J Park Dis 10(4):1779\u20131786. https:\/\/doi.org\/10.3233\/JPD-202163","journal-title":"J Park Dis"},{"issue":"1","key":"7091_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41746-022-00603-y","volume":"5","author":"N Goodson","year":"2022","unstructured":"Goodson N, Wicks P, Morgan J, Hashem L, Callinan S, Reites J (2022) Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion. NPJ Digit Med 5(1):58. https:\/\/doi.org\/10.1038\/s41746-022-00603-y","journal-title":"NPJ Digit Med"},{"issue":"6","key":"7091_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa2016638","volume":"383","author":"DR Boulware","year":"2020","unstructured":"Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Hullsiek KH (2020) A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 383(6):517\u2013525. https:\/\/doi.org\/10.1056\/NEJMoa2016638","journal-title":"N Engl J Med"},{"issue":"22","key":"7091_CR38","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.2020.22760","volume":"324","author":"EJ Lenze","year":"2020","unstructured":"Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE, Miller JP, Yang L, Yingling M, Avidan MS, Reiersen AM (2020) Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial. JAMA 324(22):2292\u20132300. https:\/\/doi.org\/10.1001\/jama.2020.22760","journal-title":"JAMA"},{"issue":"7","key":"7091_CR39","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00296-019-04302-y","volume":"39","author":"AH Opinc","year":"2019","unstructured":"Opinc AH, Brzezi\u0144ska OE, Makowska JS (2019) Disability in idiopathic inflammatory myopathies: questionnaire-based study. Rheumatol Int 39(7):1213\u20131220. https:\/\/doi.org\/10.1007\/s00296-019-04302-y","journal-title":"Rheumatol Int"},{"key":"7091_CR40","doi-asserted-by":"publisher","first-page":"1282570","DOI":"10.3389\/fdgth.2024.1282570","volume":"6","author":"A Seid","year":"2024","unstructured":"Seid A, Fufa DD, Bitew ZW (2024) The use of internet-based smartphone apps consistently improved consumers\u2019 healthy eating behaviors: a systematic review of randomized controlled trials. Front Digit Health 6:1282570. https:\/\/doi.org\/10.3389\/fdgth.2024.1282570","journal-title":"Front Digit Health"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07091-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07091-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07091-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:07:57Z","timestamp":1727672877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07091-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["7091"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07091-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Pittsburgh Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Dr. Rohit Aggarwal has received research grants from Boehringer Ingelheim (BI), Bristol-Myers Squibb, EMD Serono, Janssen, Mallinckrodt, Pfizer, and Q32. Dr. Rohit Aggarwal has received consulting fees from Actigraph, Alexion, ANI Pharmaceutical, Argenx, AstraZeneca, Boehringer Ingelheim, Bristol Myers-Squibb, CabalettaBio, Capella, Corbus, CSL Behring, EMD Serono, Galapagos, Horizontal Therapeutics, I-Cell, Immunovant, Janssen, Kezar, Kyverna, Merck, Novartis, Nuvig Therapeutic, Octapharma, Pfizer, Regeneron, Roivant, Sanofi, and Teva.The other authors have disclosed no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}